The hypothesis put forward in the present study is that NT-proBNP levels may stratify patients with coronary artery disease into two subgroups where the biomarkers related to mineral metabolism as well as those associated with inflammation may have a different prognostic value. This evidence concerns the gene NPPB and coronary artery disorder.